TEMODAR 180 mg Logo (Temodar Temozolomide 180 mg)
Generic Name: temozolomide
Pill imprint TEMODAR 180 mg Logo has been identified as Temodar Temozolomide 180 mg.
Temodar is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temodar Temozolomide 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- temozolomide
- Imprint:
- TEMODAR 180 mg Logo
- Strength:
- Temozolomide 180 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Schering
- National Drug Code (NDC):
- 00085-1430
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
sodium starch glycolate type A potato
tartaric acid
stearic acid
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
water
ammonia
potassium hydroxide
ferric oxide red
gelatin
ferric oxide yellow
titanium dioxide
sodium lauryl sulfate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5980 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about Temodar (temozolomide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
